English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Biogen
Bree Gonzales
| Jun 9, 2021
Biogen gets FDA approval for Alzheimer's treatment: 'the first therapy to target the underlying disease process'
Carrie Bradon
| Nov 30, 2017
Biogen names new chief financial officer
Carrie Bradon
| Nov 27, 2017
Biogen to present at conference this month
Nicholas Gueguen
| Jun 11, 2017
European Commission OKs Spinraza to fight spinal muscular atrophy
Jeff Gantt
| Dec 14, 2016
Biogen presents PRIME study data at clinical trials meeting
Amanda Rupp
| Sep 16, 2016
New data for Zinbryta support long-term safety profile
Amanda Rupp
| Aug 12, 2016
Biogen launches new company dedicated to hemophilia
Amanda Rupp
| Jun 23, 2016
McKenzie named new Biogen executive vice president
Trending
+
Marketing
Patient Daily
| Sep 17, 2025
Patients Come First spokesperson: Drug ads 'are putting lives at risk by encouraging people to abandon essential treatments'
+
Regulatory
Patient Daily
| Sep 17, 2025
PhRMA’s Senior Director on 340B: 'State and federal investigations have shown 340B is often exploited for profit'
+
Pharmaceuticals
Patient Daily
| Sep 23, 2025
Wall Street Journal editorial board alleges hospitals misuse 340B program
Patient Daily
| Sep 19, 2025
ENT specialist on ongoing chronic sinus cases: ‘Some of it could be incomplete surgery’
